Theranos Investor Conference Presentation Deck

Clinical Chemistry: Precision Study Overview Sample type and matrix Control levels Study Design Analysis Li-Hep venous plasma Low analyte concentration High analyte concentration 3 miniLabs x 5 Days x 5 Tests per day (CLSI EP05-A3) Analysis of variance to determine repeatability, within-lab variability, and reproducibility This technology has not been cleared or approved by the FDA and is not for sale in the United States. theranos 23

View entire presentation